NasdaqGS:TENB
NasdaqGS:TENBSoftware

Tenable (TENB) Valuation Check After New U.S. GSA OneGov Federal Cloud Security Agreement

Tenable Holdings (TENB) just locked in a OneGov agreement with the U.S. GSA, opening the door to wider adoption of its FedRAMP authorized cloud security across federal agencies, including the Department of Defense, through 2027. See our latest analysis for Tenable Holdings. Even with this federal tailwind and a new CTO sharpening its AI and exposure management strategy, Tenable’s momentum has cooled lately. The stock has delivered a roughly mid 30 percent year to date share price return and a...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Will Cirrus Logic's (CRUS) Automotive-Grade Haptics Launch Redefine Its Diversification Narrative?

In December 2025, Cirrus Logic launched its first AEC-Q100 automotive-qualified closed-loop haptic drivers, the CS40L51, CS40L52 and CS40L53, aimed at delivering high-definition tactile feedback across in-cabin interfaces such as displays, steering wheels and smart surfaces. This move extends Cirrus Logic’s haptics expertise from consumer electronics into automotive, potentially opening a new end market where consistent, premium tactile user experiences are becoming a key interior design...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

Patria Investments (PAX): Evaluating Valuation After Leadership Reshuffle and New Global COO Appointment

Patria Investments (PAX) just reshuffled key leadership, naming a new Global COO and planning a CFO transition for 2026, with these moves aimed at tightening execution as the stock rides solid recent momentum. See our latest analysis for Patria Investments. Those leadership upgrades come as Patria’s 1 month share price return of 9.81% and 37.10% share price return year to date, alongside a 43.04% 1 year total shareholder return, signal that momentum is still building rather than fading around...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Amicus Therapeutics (FOLD): Assessing Valuation After a 30% Monthly and 65% Three-Month Share Price Surge

Amicus Therapeutics (FOLD) has quietly delivered a strong run lately, with the stock climbing over 30% in the past month and roughly 65% over the past 3 months. See our latest analysis for Amicus Therapeutics. That surge sits on top of a solid backdrop, with the share price return over the past year also firmly positive. This suggests sentiment is shifting toward Amicus as its rare disease portfolio matures and execution risks feel lower. If Amicus has sparked your interest, it is worth...
TSE:1808
TSE:1808Consumer Durables

HASEKO (TSE:1808) Treasury Share Cancellation Triggers Fresh Look at an Already Stretched Valuation

HASEKO (TSE:1808) just approved the cancellation of 8,314,500 treasury shares, about 3% of its float. This is a tidy balance sheet move that can subtly lift per share metrics and shareholder appeal. See our latest analysis for HASEKO. The move comes after a powerful run, with the share price up around 9% over the past month and a year to date share price return above 50%. The five year total shareholder return of well over 200% shows long term momentum is still very much intact. If this kind...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

Interactive Brokers Group (IBKR): Valuation Check After the New IBKR GlobalTrader App Redesign and Tech Upgrades

Interactive Brokers Group (IBKR) just rolled out a redesigned IBKR GlobalTrader app, and that tech upgrade is exactly what has traders revisiting the stock, looking at how product execution ties into future growth. See our latest analysis for Interactive Brokers Group. The redesigned app lands after a steady run of fintech upgrades and geographic expansion, including new UAE equity access and IBKR Desktop enhancements. The share price now stands at $64.26, with momentum underpinned by a...
NYSE:ACVA
NYSE:ACVACommercial Services

How Investors May Respond To ACV Auctions (ACVA) CEO Share Buying Amid Analyst Rating Downgrade

Recently, ACV Auctions’ CEO bought more than 31,000 company shares, even as a major financial firm shifted its rating from Buy to Hold, highlighting conflicting signals for investors. This rare combination of insider conviction and external caution throws a spotlight on ACV’s underlying business quality, cash generation challenges, and competitive position. Next, we’ll explore how the CEO’s sizable insider purchase might influence ACV Auctions’ growth-focused investment narrative and...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Is Activist Pressure After Carbon6 Forcing a Rethink of SPS Commerce’s (SPSC) Capital Allocation Discipline?

SPS Commerce, a long-time provider of cloud-based supply chain management software, has recently faced pressure after its early‑2025 Carbon6 acquisition was undermined by Amazon marketplace rule changes and activist investor Anson began pushing for a potential sale of the company. This combination of a misjudged move into the Amazon seller ecosystem and escalating activist involvement has raised fresh questions about SPS Commerce's capital allocation discipline and boardroom...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Aurora Innovation (AUR): Valuation Check After Landmark Autonomous Proppant Hauling Deal in the Permian Basin

Aurora Innovation (AUR) just took a meaningful commercial step, partnering with Detmar Logistics to run 24/7 autonomous proppant hauls in the Permian Basin, the first frac sand runs on public roads using driverless trucks. See our latest analysis for Aurora Innovation. The deal lands at a time when sentiment on Aurora has been choppy, with a recent 10.05% 1 month share price return not enough to offset a roughly 32% year to date share price decline, and a far stronger three year total...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Does Apple’s Latest AI Push Justify Today’s Lofty Share Price?

If you are wondering whether Apple's stock is still worth buying at these levels, you are not alone. This article is going to tackle that value question head on. Despite some recent choppiness, with the share price down about 1.7% over the last week but still up 12.2% year to date and 8.0% over the past year, investors are clearly still betting on Apple's long term growth story. Recent headlines have centered on Apple's push into AI features across its product ecosystem and renewed focus on...
TSXV:NFG
TSXV:NFGMetals and Mining

New Found Gold (TSXV:NFG): Valuation Check After Financing Milestone and First Production Timeline Set for 2025

New Found Gold (TSXV:NFG) just checked off two major milestones: finishing construction at its Hammerdown open pit and securing $30 million in financing, setting up first gold production in the second half of 2025. See our latest analysis for New Found Gold. Those milestones seem to be reinvigorating sentiment, with a roughly 33% 1 month share price return and a 68% 1 year total shareholder return contrasting with still negative 3 year total shareholder returns. This suggests momentum is...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Assessing Golar LNG (NasdaqGS:GLNG)’s Valuation After Its Recent Share Price Rebound

Golar LNG (GLNG) has quietly outperformed the broader energy sector over the past month, gaining about 6%, even as its past 3 months and year to date returns remain negative. See our latest analysis for Golar LNG. That recent 1 month share price return of 5.54% looks more like a relief rally than a full trend change, given the weaker year to date share price performance and still solid 5 year total shareholder return of 350.46%. If Golar’s move has you watching the energy space more closely,...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Valuation Check After Fresh Buy Ratings and Higher 2026 Cloud Revenue Outlook

Atlassian (TEAM) just picked up fresh Wall Street support as new coverage highlighted its long term growth story, while the company lifted its 2026 cloud revenue outlook and reaffirmed its multi year expansion targets. See our latest analysis for Atlassian. Those upbeat growth signals are arriving after a choppy run, with Atlassian’s share price now at $161.07 and showing a 1 month share price return of 10.11 percent but a much weaker year to date share price return of negative 33.55 percent...
NYSE:GXO
NYSE:GXOLogistics

GXO Logistics (GXO): Assessing Valuation After Strategic Leadership Transitions and Post‑Acquisition Realignment

GXO Logistics (GXO) just reshuffled its leadership bench, adding a new Chief Commercial Officer, a new Chief Operating Officer and an incoming Non Executive Chairman, a coordinated move that is catching investors attention. See our latest analysis for GXO Logistics. The leadership shake up comes after a strong run, with GXO’s share price returning about 12 percent over the past month and roughly 24 percent year to date, while its one year total shareholder return of about 27 percent suggests...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron (CVX): Assessing Valuation After Recent Share Price Weakness and Long-Term Return Strength

Chevron (CVX) has quietly lagged the broader market over the past 3 months, even as profits improved and oil stayed reasonably firm, which may present an interesting entry point for long term income focused investors. See our latest analysis for Chevron. Over the past year Chevron has delivered a modestly positive year to date share price return and a solid 1 year total shareholder return of 8.22 percent. However, recent 3 month share price weakness suggests momentum has cooled for now, even...
ASX:DUI
ASX:DUICapital Markets

ASX Dividend Stocks Spotlight With These 3 Top Picks

As Australian shares experience a modest uptick following Wall Street's positive momentum, investors are keenly observing the interplay between domestic and international economic trends. In this environment, dividend stocks stand out as attractive options for those seeking steady income amidst fluctuating market conditions.
ASX:APX
ASX:APXIT

ASX Penny Stocks To Watch In December 2025

As Australian shares experience a modest uptick, following Wall Street's lead, investors are keenly observing the market dynamics influenced by global economic indicators. Amidst these developments, penny stocks remain an intriguing area of investment, offering potential opportunities in smaller or less-established companies. While the term "penny stocks" may seem outdated, these investments can still provide value when backed by strong financials and growth prospects.
TSE:4666
TSE:4666Commercial Services

PARK24 (TSE:4666): Reassessing Valuation After Dividend Hike, Earnings Growth Guidance and Early Loan Repayment Plan

PARK24 (TSE:4666) just packed several shareholder friendly moves into one update, lifting its dividend outlook, guiding for higher sales and profits, and planning early repayment of a large subordinated loan. See our latest analysis for PARK24. The upbeat guidance, richer dividend outlook and early loan repayment plan come after a choppy stretch. The latest ¥2,067.5 share price sits against a modestly negative year to date share price return but a solid positive five year total shareholder...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Is Celldex (CLDX) Using Barzolvolimab’s Phase 3 Urticaria Bet To Redefine Its Core Strategy?

In December 2025, Celldex Therapeutics began a global Phase 3 EMBARQ-ColdU and SD trial of barzolvolimab in adults with cold urticaria and symptomatic dermographism who remain symptomatic despite H1 antihistamines or biologics, enrolling about 240 patients across approximately 75 sites in 7 countries with complete response at Week 12 as the primary endpoint. This late-stage program builds directly on earlier placebo-controlled Phase 2 data showing rapid, durable clinical responses and...
NYSE:EDU
NYSE:EDUConsumer Services

New Oriental (NYSE:EDU) Valuation After Serenity Capital’s Big Bet on Its Post‑Crackdown Transformation

Serenity Capital’s decision to lift New Oriental Education & Technology Group (NYSE:EDU) into its top holdings is a clear vote of confidence in the company’s post crack down transformation and earnings trajectory. See our latest analysis for New Oriental Education & Technology Group. That conviction lines up with the market’s tone, with a 30 day share price return of 7.42 percent and a three year total shareholder return of 47.27 percent suggesting momentum is rebuilding after a tougher...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Assessing Alvotech (NasdaqGM:ALVO)’s Valuation After FDA Setback and 2025 Guidance Cut

Alvotech (NasdaqGM:ALVO) stock has been under pressure after the FDA issued a Complete Response Letter related to deficiencies at its Reykjavik manufacturing site, which forced the company to cut 2025 revenue and EBITDA guidance. See our latest analysis for Alvotech. Those manufacturing setbacks and shareholder investigations have clearly reset expectations, with the 90 day share price return of minus 38.83 percent and year to date share price return of minus 62.77 percent showing momentum is...
NYSE:NIO
NYSE:NIOAuto

NIO (NYSE:NIO) Reaches 30,000 ES8 Deliveries – What Does This Growth Milestone Say About Its Valuation?

NIO (NIO) just hit its 30,000th ES8 delivery barely three months after launch, even while juggling chip and battery shortages, and that rapid scale up is exactly what has analysts rethinking the stock’s trajectory. See our latest analysis for NIO. That milestone caps a choppy year in the market, with NIO’s share price at $4.99 and a positive year to date share price return, but a weak 3 year total shareholder return signalling momentum is only tentatively rebuilding as investors weigh rapid...
NYSE:UVV
NYSE:UVVTobacco

How Investors May Respond To Universal (UVV) Expanding Its US$1.40 Billion Long-Term Credit Facility

Universal Corporation recently entered into a new bank credit agreement that took effect on December 9, 2025, establishing a US$1.40 billion senior unsecured facility comprising a five-year US$780 million revolving credit line, a funded US$275 million five-year term loan, and a funded US$345 million seven-year term loan, replacing its prior US$1.15 billion facility. This expanded mix of longer-dated term loans and a larger revolving facility increases Universal’s financial flexibility,...
NYSE:CPT
NYSE:CPTResidential REITs

Camden Property Trust (CPT): Reassessing Valuation After Dual Listing, 2025 Guidance Upgrade and JP Morgan Rating Boost

Camden Property Trust (CPT) just packed three catalysts into one stretch: a fresh NYSE Texas dual listing, higher 2025 guidance, and a JP Morgan upgrade, all reshaping how investors are sizing up the stock. See our latest analysis for Camden Property Trust. Those catalysts arrive after a choppy stretch, with the share price at $107.28 and a negative year to date share price return but a positive five year total shareholder return suggesting longer term momentum is still intact even as near...